Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 7 results.
User Information
Export Records
  1. 1.   Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer
  2. Furusawa, Takashi; Cavero, Renzo; Liu, Yue; Li, Haojian; Xu,Xia; Andresson,Thorkell; Reinhold, William; White, Olivia; Boufraqech, Myriem; Meyer,Thomas; Hartmann, Oliver; Diefenbacher, Markus E; Pommier, Yves; Weyemi, Urbain
  3. Molecular Carcinogenesis. 2024, Feb 27;
  1. 2.   ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer
  2. Schultz, Christopher W; Zhang, Yang; Elmeskini, Rajaa; Zimmermann, Astrid; Fu, Haiqing; Murai, Yasuhisa; Wangsa, Darawalee; Kumar, Suresh; Takahashi, Nobuyuki; Atkinson,Devon; Saha, Liton Kumar; Lee, Chien-Fei; Elenbaas, Brian; Desai, Parth; Sebastian, Robin; Sharma, Ajit Kumar; Abel, Melissa; Schroeder, Brett; Krishnamurthy, Manan; Kumar, Rajesh; Roper, Nitin; Aladjem, Mirit; Zenke, Frank T; Ohler,Zoe; Pommier, Yves; Thomas, Anish
  3. EMBO Molecular Medicine. 2023, Jul 25; e17313.
  1. 3.   A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers
  2. Hanada, Ken-Ichi; Zhao, Chihao; Gil-Hoyos, Raul; Gartner, Jared J; Chow-Parmer, Christopher; Lowery, Frank J; Krishna, Sri; Prickett, Todd D; Kivitz, Scott; Parkhurst, Maria R; Wong,Nathan; Rae, Zachary; Kelly, Michael C; Goff, Stephanie L; Robbins, Paul F; Rosenberg, Steven A; Yang, James C
  3. Cancer Cell. 2022, Apr 13;
  1. 4.   Whole Exome Profiling of NSCLC Among African Americans
  2. Arauz, Rony F; Byun, Jung S; Tandon,Mayank; Sinha, Sanju; Kuhn,Skyler; Taylor, Sheryse; Zingone, Adriana; Mitchell, Khadijah A; Pine, Sharon R; Gardner, Kevin; Perez-Stable, Eliseo J; Napoles, Anna M; Ryan, Bríd M
  3. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020, DEC; 15(12): 1880-1892.
  1. 5.   Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patients
  2. Castellanos-Rizaldos, Elena; Zhang, Xuan; Tadigotla, Vasisht R; Grimm, Dominik G; Karlovich,Chris; Raez, Luis E; Skog, Johan K
  3. Oncotarget. 2019, Apr 23; 10(30): 2911-2920.
  1. 6.   Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor
  2. Helman, Elena; Nguyen, Minh; Karlovich, Chris; Despain, Darrin; Choquette, A Karin; Spira, Alexander I; Yu, Helena A; Camidge, D Ross; Harding, Thomas C; Lanman, Richard B; Simmons, Andrew D
  3. Clinical lung cancer. 2018, Nov; 19(6): 518-530.e7.
  1. 7.   Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent
  2. Teicher, Beverly A; Silvers, Thomas; Selby, Michael; Delosh, Rene; Laudeman, Julie; Ogle, Chad; Reinhart, Russell; Parchment, Ralph; Krushkal, Julia; Sonkin, Dmitriy; Rubinstein, Larry; Morris, Joel; Evans, David
  3. Cancer Medicine. 2017, Aug; 6(8): 1952-1964.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel